Literature DB >> 16931008

Design, synthesis, and biological evaluation of a new class of small molecule peptide mimetics targeting the melanocortin receptors.

James P Cain1, Alexander V Mayorov, Minying Cai, Hui Wang, Bahar Tan, Kevin Chandler, YeonSun Lee, Ravil R Petrov, Dev Trivedi, Victor J Hruby.   

Abstract

A new bicyclic template has been developed for the synthesis of peptide mimetics. Straightforward synthetic steps, starting from amino acids, allow the facile construction of a wide range of analogs. This system was designed to target the melanocortin receptors (MCRs), with functional group selection based on a known pharmacophore and guidance from molecular modeling to rationally identify positional and stereochemical isomers likely to be active. The functions of hMCRs are critical to myriad biological activities, including pigmentation, steroidogenesis, energy homeostasis, erectile activity, and inflammation. These G-protein-coupled receptors (GPCRs) are targets for drug discovery in a number of areas, including cancer, pain, and obesity therapeutics. All compounds from this series tested to date are antagonists which bind with high affinity. Importantly, many are highly selective for a particular MCR subtype, including some of the first completely hMC5R-selective antagonists reported.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16931008      PMCID: PMC1810397          DOI: 10.1016/j.bmcl.2006.07.015

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  86 in total

1.  Design and pharmacology of N-[(3R)-1,2,3,4-tetrahydroisoquinolinium- 3-ylcarbonyl]-(1R)-1-(4-chlorobenzyl)- 2-[4-cyclohexyl-4-(1H-1,2,4-triazol- 1-ylmethyl)piperidin-1-yl]-2-oxoethylamine (1), a potent, selective, melanocortin subtype-4 receptor agonist.

Authors:  Iyassu K Sebhat; William J Martin; Zhixiong Ye; Khaled Barakat; Ralph T Mosley; David B R Johnston; Raman Bakshi; Brenda Palucki; David H Weinberg; Tanya MacNeil; Rubana N Kalyani; Rui Tang; Ralph A Stearns; Randy R Miller; Constantin Tamvakopoulos; Alison M Strack; Erin McGowan; Doreen E Cashen; Jennifer E Drisko; Gary J Hom; Andrew D Howard; D Euan MacIntyre; Lex H T van der Ploeg; Arthur A Patchett; Ravi P Nargund
Journal:  J Med Chem       Date:  2002-10-10       Impact factor: 7.446

2.  Nucleotide sequence of cloned cDNA for bovine corticotropin-beta-lipotropin precursor.

Authors:  S Nakanishi; A Inoue; T Kita; M Nakamura; A C Chang; S N Cohen; S Numa
Journal:  Nature       Date:  1979-03-29       Impact factor: 49.962

3.  Inhibition of morphine tolerance by spinal melanocortin receptor blockade.

Authors:  Katarzyna Starowicz; Ilona Obara; Ryszard Przewłocki; Barbara Przewlocka
Journal:  Pain       Date:  2005-10       Impact factor: 6.961

4.  Novel 3D pharmacophore of alpha-MSH/gamma-MSH hybrids leads to selective human MC1R and MC3R analogues.

Authors:  Minying Cai; Alexander V Mayorov; Christopher Cabello; Magda Stankova; Dev Trivedi; Victor J Hruby
Journal:  J Med Chem       Date:  2005-03-24       Impact factor: 7.446

5.  Cell-free translation product containing corticotropin and beta-endorphin encoded by messenger RNA from anterior lobe and intermediate lobe of bovine pituitary.

Authors:  S Nakanishi; A Inoue; S Taii; S Numa
Journal:  FEBS Lett       Date:  1977-12-01       Impact factor: 4.124

Review 6.  Neuropathic pain: a possible role for the melanocortin system?

Authors:  D H Vrinten; C J Kalkman; R A Adan; W H Gispen
Journal:  Eur J Pharmacol       Date:  2001-10-19       Impact factor: 4.432

7.  Linkage and association studies between the melanocortin receptors 4 and 5 genes and obesity-related phenotypes in the Québec Family Study.

Authors:  Y C Chagnon; W J Chen; L Pérusse; M Chagnon; A Nadeau; W O Wilkison; C Bouchard
Journal:  Mol Med       Date:  1997-10       Impact factor: 6.354

8.  Melanocortin-5 receptor deficiency promotes defensive behavior in male mice.

Authors:  Caurnel Morgan; Ruth E Thomas; Roger D Cone
Journal:  Horm Behav       Date:  2004-01       Impact factor: 3.587

9.  Cloning of the mouse agouti gene predicts a secreted protein ubiquitously expressed in mice carrying the lethal yellow mutation.

Authors:  M W Miller; D M Duhl; H Vrieling; S P Cordes; M M Ollmann; B M Winkes; G S Barsh
Journal:  Genes Dev       Date:  1993-03       Impact factor: 11.361

10.  Binding and cAMP studies of melanotropin peptides with the cloned human peripheral melanocortin receptor, hMC1R.

Authors:  C Haskell-Luevano; H Miwa; C Dickinson; V J Hruby; T Yamada; I Gantz
Journal:  Biochem Biophys Res Commun       Date:  1994-11-15       Impact factor: 3.575

View more
  14 in total

1.  Approaches to the rational design of selective melanocortin receptor antagonists.

Authors:  Victor J Hruby; Minying Cai; Joel Nyberg; Dhanasekaran Muthu
Journal:  Expert Opin Drug Discov       Date:  2011-03-24       Impact factor: 6.098

Review 2.  Melanotropins as drugs for the treatment of obesity and other feeding disorders: potential and problems.

Authors:  Minying Cai; Joel Nyberg; Victor J Hruby
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

Review 3.  Design of peptide and peptidomimetic ligands with novel pharmacological activity profiles.

Authors:  Victor J Hruby; Minying Cai
Journal:  Annu Rev Pharmacol Toxicol       Date:  2013       Impact factor: 13.820

Review 4.  Design of novel melanocortin receptor ligands: multiple receptors, complex pharmacology, the challenge.

Authors:  Victor J Hruby; Minying Cai; James Cain; Joel Nyberg; Dev Trivedi
Journal:  Eur J Pharmacol       Date:  2011-01-03       Impact factor: 4.432

5.  Incorporation of Agouti-Related Protein (AgRP) Human Single Nucleotide Polymorphisms (SNPs) in the AgRP-Derived Macrocyclic Scaffold c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-dPro] Decreases Melanocortin-4 Receptor Antagonist Potency and Results in the Discovery of Melanocortin-5 Receptor Antagonists.

Authors:  Zoe M Koerperich; Mark D Ericson; Katie T Freeman; Robert C Speth; Irina D Pogozheva; Henry I Mosberg; Carrie Haskell-Luevano
Journal:  J Med Chem       Date:  2020-01-06       Impact factor: 7.446

6.  Solid-phase peptide head-to-side chain cyclodimerization: discovery of C(2)-symmetric cyclic lactam hybrid α-melanocyte-stimulating hormone (MSH)/agouti-signaling protein (ASIP) analogues with potent activities at the human melanocortin receptors.

Authors:  Alexander V Mayorov; Minying Cai; Erin S Palmer; Zhihua Liu; James P Cain; Josef Vagner; Dev Trivedi; Victor J Hruby
Journal:  Peptides       Date:  2010-08-03       Impact factor: 3.750

7.  Adventures in peptides and science with students! The joys of research.

Authors:  Victor J Hruby
Journal:  Biopolymers       Date:  2013-04       Impact factor: 2.505

8.  Beta-turn secondary structure and melanocortin ligands.

Authors:  Erica M Haslach; Jay W Schaub; Carrie Haskell-Luevano
Journal:  Bioorg Med Chem       Date:  2008-03-04       Impact factor: 3.641

9.  Substitution of arginine with proline and proline derivatives in melanocyte-stimulating hormones leads to selectivity for human melanocortin 4 receptor.

Authors:  Hongchang Qu; Minying Cai; Alexander V Mayorov; Paolo Grieco; Morgan Zingsheim; Dev Trivedi; Victor J Hruby
Journal:  J Med Chem       Date:  2009-06-25       Impact factor: 7.446

Review 10.  Design, synthesis and biological evaluation of ligands selective for the melanocortin-3 receptor.

Authors:  Victor J Hruby; Minying Cai; James P Cain; Alexander V Mayorov; Matthew M Dedek; Devendra Trivedi
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.